Anthem Biosciences Share Price Today | Stock Price & Anthem Biosciences Share Screener

Track the current stock price of Anthem Biosciences with an interactive chart. Analyse ANTHEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Anthem Biosciences stock quote in one place.

The quote of ₹851.90 sits between the 52-week low of ₹587.85 and the 52-week high of ₹957.80, and the latest session moved -0.45% from the previous close.

Screen Anthem Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANTHEM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Biotechnology industry, and it trades under ISIN INE0CZ201020.

Classification

Identifiers and Leadership

Screen ANTHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹2,808, up from ₹2,398 in 2024.

Latest statistics put total assets at ₹2,808 and shareholder funds at ₹2,410, with a leverage ratio of 0.08.

Screen Anthem Biosciences income statement and profit fundamentals. Analyze ANTHEM quarterly results. Anthem Biosciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Dec, revenue was ₹457 and net profit was ₹93, equal to earnings per unit of ₹1.65, at an operating margin of 31%.

In that period expenses were ₹291, interest cost ₹0 and tax ₹38. The next period listed, 2025-Sept, shows revenue of ₹598 and net profit of ₹173.

Screen ANTHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹418, and net cash flow was an inflow of ₹133.

Over the same period, investing activities used ₹152 and financing activities used ₹134.

See Anthem Biosciences shareholding pattern with promoter, FII, and DII holdings. Check Anthem Biosciences promoter holding and ownership changes for ANTHEM on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Jul, promoters held 76.88%, foreign institutions 0.00%, domestic institutions 0.00% and the public 0.00%, spread across 761 shareholders.

The shareholder count was 761 in 2025-Jul, compared with 217,681 in 2025-Sept.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Anthem Biosciences. Anthem Biosciences dividend yield can be compared with peers and other stocks in the market.

See which indices include Anthem Biosciences stock. Check ANTHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Anthem Biosciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Anthem Biosciences stock events that may affect ANTHEM share price, along with derivatives, futures and options activity and sector gainers.

3 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated February 5, 2026, with a record date of February 5, 2026.

It is followed by Quarterly Result Announcement dated November 8, 2025 and Quarterly Result Announcement dated August 13, 2025.

Screen ANTHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 6 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen ANTHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 28, 2026.

The next most recent announcements are dated February 23, 2026 and February 9, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 6 cash flow years and 4 shareholding periods. Information is provided for research and is not investment advice.